Understand this story
Opentrons Labworks Inc. has completed a $40 million Series E financing round, led by Avego with participation from BroadOak Capital Partners, with the funds to be used to expand robotics, software, and data infrastructure. According to SiliconANGLE, its two benchtop robots, Flex and OT-2, can automate laboratory operations such as pipetting, DNA extraction, PCR, and protein purification. The company says it has deployed more than 11,000 robots in over 80 countries, covering 90% of the world's top 20 pharmaceutical companies. No subsequent developments have been disclosed at this time.
AI-generated from public reports
Latest development · Report
Lab automation company Opentrons closes $40 million Series E fundingDevelopments
1 confirmed developments
- Source:SiliconANGLE
Reports and discussion timeline
Browse reports and discussion by time. Their evidence levels remain distinct.
Oct 30
SiliconANGLE
Lab automation company Opentrons closes $40 million Series E funding
AI-driven lab robotics company Opentrons has closed a $40 million Series E funding round, led by Avego with participation from BroadOak Capital Partners, with the funds to be used to expand its robotics, software, and data infrastructure. Its two benchtop robots, Flex and OT-2, can automate experimental operations such as pipetting, DNA extraction, PCR, and protein purification. The company says it has deployed more than 11,000 robots in over 80 countries, covering 90% of the world's top 20 pharmaceutical companies.